These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 37750467)

  • 21. Immunogenicity and protective potential of chimeric virus-like particles containing SARS-CoV-2 spike and H5N1 matrix 1 proteins.
    Chen J; Xu W; Li L; Yi L; Jiang Y; Hao P; Xu Z; Zou W; Li P; Gao Z; Tian M; Jin N; Ren L; Li C
    Front Cell Infect Microbiol; 2022; 12():967493. PubMed ID: 35923799
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Virus-like particle - mediated delivery of the RIG-I agonist M8 induces a type I interferon response and protects cells against viral infection.
    Palermo E; Alexandridi M; Di Carlo D; Muscolini M; Hiscott J
    Front Cell Infect Microbiol; 2022; 12():1079926. PubMed ID: 36590581
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synergistic surface-enhanced Raman scattering effect to distinguish live SARS-CoV-2 S pseudovirus.
    Sitjar J; Xu HZ; Liu CY; Wang JR; Liao JD; Tsai HP; Lee H; Liu BH; Chang CW
    Anal Chim Acta; 2022 Feb; 1193():339406. PubMed ID: 35058004
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assembly and Entry of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2): Evaluation Using Virus-Like Particles.
    Kumar B; Hawkins GM; Kicmal T; Qing E; Timm E; Gallagher T
    Cells; 2021 Apr; 10(4):. PubMed ID: 33918600
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ultrasensitive detection of SARS-CoV-2 S protein with aptamers biosensor based on surface-enhanced Raman scattering.
    Gu MM; Guan PC; Xu SS; Li HM; Kou YC; Lin XD; Kathiresan M; Song Y; Zhang YJ; Jin SZ; Li JF
    J Chem Phys; 2023 Jan; 158(2):024203. PubMed ID: 36641419
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A non-invasive ultrasensitive diagnostic approach for COVID-19 infection using salivary label-free SERS fingerprinting and artificial intelligence.
    Karunakaran V; Joseph MM; Yadev I; Sharma H; Shamna K; Saurav S; Sreejith RP; Anand V; Beegum R; Regi David S; Iype T; Sarada Devi KL; Nizarudheen A; Sharmad MS; Sharma R; Mukhiya R; Thouti E; Yoosaf K; Joseph J; Sujatha Devi P; Savithri S; Agarwal A; Singh S; Maiti KK
    J Photochem Photobiol B; 2022 Sep; 234():112545. PubMed ID: 36049288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Construction of SARS-CoV-2 Virus-Like Particles by Mammalian Expression System.
    Xu R; Shi M; Li J; Song P; Li N
    Front Bioeng Biotechnol; 2020; 8():862. PubMed ID: 32850726
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SARS-CoV-2 Virus-like Particles Produced by a Single Recombinant Baculovirus Generate Anti-S Antibody and Protect against Variant Challenge.
    Sullivan E; Sung PY; Wu W; Berry N; Kempster S; Ferguson D; Almond N; Jones IM; Roy P
    Viruses; 2022 Apr; 14(5):. PubMed ID: 35632656
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RG203KR Mutations in SARS-CoV-2 Nucleocapsid: Assessing the Impact Using a Virus-Like Particle Model System.
    Raheja H; Das S; Banerjee A; P D; C D; Mukhopadhyay D; Ramachandra SG; Das S
    Microbiol Spectr; 2022 Aug; 10(4):e0078122. PubMed ID: 35862952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Model of the SARS-CoV-2 Virus for Development of a DNA-Modified, Surface-Enhanced Raman Spectroscopy Sensor with a Novel Hybrid Plasmonic Platform in Sandwich Mode.
    Samodelova MV; Kapitanova OO; Meshcheryakova NF; Novikov SM; Yarenkov NR; Streletskii OA; Yakubovsky DI; Grabovenko FI; Zhdanov GA; Arsenin AV; Volkov VS; Zavyalova EG; Veselova IA; Zvereva MI
    Biosensors (Basel); 2022 Sep; 12(9):. PubMed ID: 36140152
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Baculovirus-Free SARS-CoV-2 Virus-like Particle Production in Insect Cells for Rapid Neutralization Assessment.
    Jaron M; Lehky M; Zarà M; Zaydowicz CN; Lak A; Ballmann R; Heine PA; Wenzel EV; Schneider KT; Bertoglio F; Kempter S; Köster RW; Barbieri SS; van den Heuvel J; Hust M; Dübel S; Schubert M
    Viruses; 2022 Sep; 14(10):. PubMed ID: 36298643
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Construction of SARS-CoV-2 virus-like particles in plant.
    Moon KB; Jeon JH; Choi H; Park JS; Park SJ; Lee HJ; Park JM; Cho HS; Moon JS; Oh H; Kang S; Mason HS; Kwon SY; Kim HS
    Sci Rep; 2022 Jan; 12(1):1005. PubMed ID: 35046461
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Label-Free Detection and Identification of SARS-CoV-2 Using Surface-Enhanced Raman Spectroscopy and Principal Component Analysis.
    Zhou L; Vestri A; Marchesano V; Rippa M; Sagnelli D; Picazio G; Fusco G; Han J; Zhou J; Petti L
    Biosensors (Basel); 2023 Dec; 13(12):. PubMed ID: 38131774
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ultrasensitive detection of SARS-CoV-2 spike protein in untreated saliva using SERS-based biosensor.
    Zhang M; Li X; Pan J; Zhang Y; Zhang L; Wang C; Yan X; Liu X; Lu G
    Biosens Bioelectron; 2021 Oct; 190():113421. PubMed ID: 34134070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-Range SERS Detection of the SARS-CoV-2 Antigen on a Well-Ordered Gold Hexagonal Nanoplate Film.
    Wu P; Luo X; Xu Y; Zhu J; Jia W; Fang N; Cai C; Zhu JJ
    Anal Chem; 2022 Dec; 94(50):17541-17550. PubMed ID: 36475600
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Single-Nanoparticle-Based Digital SERS Sensing Platform for the Accurate Quantitative Detection of SARS-CoV-2.
    Shim JE; Kim YJ; Choe JH; Lee TG; You EA
    ACS Appl Mater Interfaces; 2022 Aug; 14(34):38459-38470. PubMed ID: 35951983
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Catching COVID: Engineering Peptide-Modified Surface-Enhanced Raman Spectroscopy Sensors for SARS-CoV-2.
    Payne TD; Klawa SJ; Jian T; Kim SH; Papanikolas MJ; Freeman R; Schultz ZD
    ACS Sens; 2021 Sep; 6(9):3436-3444. PubMed ID: 34491043
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Virus-like Particles of Nodavirus Displaying the Receptor Binding Domain of SARS-CoV-2 Spike Protein: A Potential VLP-Based COVID-19 Vaccine.
    Kumar K; Tan WS; Arshad SS; Ho KL
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A stable platform for the production of virus-like particles pseudotyped with the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) spike protein.
    Roy S; Ghani K; de Campos-Lima PO; Caruso M
    Virus Res; 2021 Apr; 295():198305. PubMed ID: 33482242
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.